Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Cytek BioSciences (CTKB)

Annual Return

Over the past 3 years, CTKB has had an average annual return of -20.55%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Jul 23, 2021, CTKB has had an average annual return of -27.02%, underperforming the benchmark SPY, which returned +13.22% annual.

202620252024202320222021
-19.80%-22.17%-28.84%-10.68%-37.44%-13.01%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-1.00%-10.39%-2.47%+4.38%-8.14%-3.31%-19.80%
2025-20.64%-12.82%-10.66%-7.48%-25.33%+22.68%+5.91%+15.01%-16.18%+12.38%+44.88%-10.62%-22.17%
2024-17.20%+1.96%-12.84%-10.43%-6.34%-0.90%+20.28%-14.45%-3.50%-10.73%+32.06%-0.63%-28.84%
2023+18.03%-14.53%-10.77%+24.90%-31.97%+9.34%+4.92%-15.18%-27.38%-23.73%+64.84%+31.41%-10.68%
2022-10.78%-6.31%-20.97%-12.34%+2.76%+10.51%+19.28%-8.98%+26.34%+5.44%-16.95%-20.80%-37.44%
2021+18.23%+2.71%-6.01%+6.54%-11.57%-19.09%-13.01%

Drawdown analysis of Cytek BioSciences (CTKB)

The maximum drawdown for the CTKB was -91.34%, occurring on May 23, 2025. This drawdown has not yet recovered.

The current CTKB drawdown is -85.50%.

Since Jul 23, 2021 CTKB has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-91.34%Sep 15, 2021926May 23, 2025OngoingOngoingOngoing
-24.90%Aug 10, 202114Aug 30, 202111Sep 15, 202125
-6.61%Jul 23, 20212Jul 27, 20211Jul 28, 20213
-6.03%Aug 3, 20212Aug 5, 20213Aug 10, 20215